Quantum Leap

Variational AI Announces Generative AI Project With Merck

Retrieved on: 
Thursday, January 25, 2024
Software, Research, General Health, Professional Services, Pharmaceutical, Venture Capital, Technology, Artificial Intelligence, Science, Biotechnology, Other Technology, Health, Other Science, Artificial intelligence, Quantum Leap, TPP, Chemistry, AI, Language, Midjourney, Drug discovery, Variational, DALL-E, Merck, Growth, Medical device

Variational AI , developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research Labs supported by the CQDM Quantum Leap program.

Key Points: 
  • Variational AI , developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research Labs supported by the CQDM Quantum Leap program.
  • “We are pleased to announce Merck as an early-access user of our Enki™ Platform,” said Handol Kim, CEO, Variational AI.
  • It designs novel molecules how other generative AI foundation models like DALL-E and Midjourney create novel images based on text prompts.
  • “CQDM is pleased to have facilitated the establishment of collaborations for Variational AI by creating beneficial links with Merck, a global biopharmaceutical organization.

Atossa Therapeutics Issues Letter to Shareholders

Retrieved on: 
Tuesday, January 9, 2024
Woman, Weill Cornell Medicine, Research, Breast cancer screening, Share repurchase, Exemestane, University, Neoadjuvant therapy, Prognosis, Cancer, Breast, Risk, Breast Cancer Research Foundation, Cell death, University of California, Mastectomy, Ductal carcinoma, Diagnosis, Nature Portfolio, Growth, Silicon, Quantum Leap, Therapy, Neoplasm, BCRF, Seminal vesicles, Breast cancer, Disease, Patient, Lymph, Apoptosis, Radiation, Letter, Recurrence, TNBC, Phenotype, DCIS, PKC, Partnership, Mayo Clinic, Plasma, Triple-negative breast cancer, AKT, Springer Nature, FDA, Biomarker, PCR, Phosphorylation, Medical imaging

SEATTLE, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announces the issuance of the following Letter to Shareholders from Steven Quay, M.D., Ph.D., the Company’s President and Chief Executive Officer:

Key Points: 
  • SEATTLE, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announces the issuance of the following Letter to Shareholders from Steven Quay, M.D., Ph.D., the Company’s President and Chief Executive Officer:
    2023 marked another year of significant progress for Atossa.
  • If you would like to learn more about the study, please visit www.atossatherapeutics.com to view a short video interview I conducted with Dr.
  • Adding to the issue is the fact that there are currently no approved treatments to reduce breast density.
  • On behalf of the board of directors, management, and employees of Atossa Therapeutics, we thank you for your investment and continued support of our Company.

Marine Toys for Tots Foundation and the Hollywood Christmas Parade: A Partnership Illuminating Hope During The Holiday Season!

Retrieved on: 
Thursday, December 14, 2023
Hallmark Channel, Record, NBC, Hope, USMC, Associated Television International, Book, Magic, LOS, Hollywood Christmas Parade, Saturday Night Live, Quantum Leap, Friends, Child, Toys for Tots, CW, Partnership, Family, Lieutenant, Life, Entertainment, Toy, Grand marshal

LOS ANGELES, Dec. 14, 2023 /PRNewswire/ -- As Marine Toys for Tots Foundation continues its impactful collaboration with the Hollywood Christmas Parade, communities across the country are invited to witness the 91st anniversary of this joyous event on December 15, 8:00 p.m. ET/PT, broadcasted nationwide on The CW.

Key Points: 
  • Lieutenant General James B. Laster, USMC (Retired), CEO of the Marine Toys for Tots Foundation, highlights the significance of this partnership: "Today's children are tomorrow's leaders.
  • "The Marine Toys for Tots Program has been a beacon of hope for over seven decades," Lieutenant General Laster continued.
  • The exposure and support from the Hollywood Christmas Parade are invaluable in bringing joy and hope to more children each year."
  • With over a decade-long partnership, the Marine Toys for Tots Foundation and the Hollywood Christmas Parade have become synonymous with delivering holiday cheer to millions of children.

Legendary Paula Abdul to be Honored at Hollywood Christmas Parade as Humanitarian of the Year

Retrieved on: 
Tuesday, November 21, 2023
Share Our Strength, Joyeux Noël, HCP, Juno Award, Kickstarter, MTV Video Music Awards, Cold Hearted, Special, Organization, Hollywood Christmas Parade, City, Young, Hollywood Walk of Fame, Personality, TED, Wig, Forever, Restless, Associated Television International, Forever Your Girl, Magic, Cancer, The Doors, Web Cartoonists' Choice Awards, Cherry Lane Theatre, Coming to America, Harry, Book, Beautiful, Opposites Attract, Music, Emphasis (typography), Quantum Leap, Organic, CW, Grammy Awards, Day, Partnership, Christmas, Straight Up, WAR, People's Choice Awards, Kate Linder, American Music Awards, Addiction, Radio personality, Days of Our Lives, American Humane, Hospital, Medal of Honor, Entertainment, Film industry, Martínez

Abdul's spirit of compassion aligns perfectly with the Hollywood Christmas Parade, a cherished tradition that has been spreading holiday cheer and fostering community spirit for an incredible 91 years.

Key Points: 
  • Abdul's spirit of compassion aligns perfectly with the Hollywood Christmas Parade, a cherished tradition that has been spreading holiday cheer and fostering community spirit for an incredible 91 years.
  • As Grand Marshal, he will lead the parade in a grand procession of Hollywood celebrities, vintage movie cars, award-winning bands, larger-than-life character balloons, and vibrant floats.
  • The Hollywood Christmas Parade, presented by Associated Television International in partnership with The City of Los Angeles, will air in primetime on The CW on December 15, 2023.
  • After several national tours, Paula enjoyed her Paula Abdul: Forever Your Girl Las Vegas residency in 2019.

Global Demand for Smart Batteries Signals Prosperous Future for Battery Management ICs

Retrieved on: 
Tuesday, November 14, 2023
Lithium, Global Information Grid, Internet of things, Electronics, Battery charger, Consumer, Growth, Consumer electronics, Battery management system, Quantum Leap, Smart city, ICS, Access, Medical device, Pet industry, Electric battery, Battery, Electric vehicle

DUBLIN, Nov. 14, 2023 /PRNewswire/ -- The "Battery Management ICs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 14, 2023 /PRNewswire/ -- The "Battery Management ICs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
  • The global market for Battery Management ICs estimated at US$7.5 Billion in the year 2022, is projected to reach a revised size of US$10.9 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030.
  • Growth in the Battery Charger ICs segment is estimated at 4.7% CAGR for the next 8-year period.
  • The Battery Management ICs market in the U.S. is estimated at US$1.2 Billion in the year 2022.

The Paley Center for Media Announces the 17th Annual PaleyFest Fall TV Previews with Citi Returning as an Official Sponsor

Retrieved on: 
Monday, September 11, 2023
Goosebumps, Star, Love, VIP, The Amazing Race, Paley Center for Media, Education, Production designer, Bertram van Munster, Dance, CBS, Love Is Blind, NBC, The D'Amelio Show, Dancing with the Stars, Citigroup, Student, Production, Quantum Leap, TLC, SHOWTIME, Costume designer, OWN, ABC, Host, Supreme court, Showrunner, Invincible, Law of the United Kingdom, Radio, Member, Netflix, Television, Film industry, Management, Paley, Chemistry

NEW YORK, Sept. 11, 2023 /PRNewswire/ -- The Paley Center for Media announced today its 17th Annual PaleyFest Fall TV Previews lineup featuring exclusive conversations with the stars, creatives, and innovators behind a selection of the season's most anticipated new and returning series. PaleyFest Fall TV Previews provide audiences with an exclusive sneak peek at the most anticipated and buzzworthy series of the upcoming fall television season. Citi is the returning Official Sponsor and Official Card of PaleyFest Fall TV Previews.

Key Points: 
  • NEW YORK, Sept. 11, 2023 /PRNewswire/ -- The Paley Center for Media announced today its 17th Annual PaleyFest Fall TV Previews lineup featuring exclusive conversations with the stars, creatives, and innovators behind a selection of the season's most anticipated new and returning series.
  • PaleyFest Fall TV Previews provide audiences with an exclusive sneak peek at the most anticipated and buzzworthy series of the upcoming fall television season.
  • Citi is the returning Official Sponsor and Official Card of PaleyFest Fall TV Previews.
  • PaleyFest Fall TV Previews will be available to the public on Friday, September 22 on the Paley Center for Media's YouTube Channel .

Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, August 8, 2023
Exercise, PROTAC, Insurance, Response evaluation criteria in solid tumors, LRRK2, SLI, Everolimus, Clinical trial, RECIST, Trae Elston, CTA, Molecule, Oncology, Research, Part, EOP, Genentech, Equity method, Sale, ARVN, Development, Neuroscience, Bayer, Quantum Leap, Patient, Investment, Enrollment, Administration, Financial toxicity, European Society of Gynaecological Oncology, Therapy, IND, LBD, AR, Pfizer, Pharmaceutical industry, Medical imaging, Dietary supplement, Life insurance, Gaius Papirius Carbo Arvina

NEW HAVEN, Conn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today reported financial results for the second quarter ended June 30, 2023 and provided a corporate update.

Key Points: 
  • We are also on track to initiate a Phase 3 trial with bavdegalutamide in the second half of the year.
  • Research and Development Expenses: Research and development expenses were $103.4 million for the quarter ended June 30, 2023, as compared with $75.3 million for the quarter ended June 30, 2022.
  • Revenues: Revenues were $54.5 million for the quarter ended June 30, 2023 as compared with $33.8 million for the quarter ended June 30, 2022.
  • Net Loss: Net loss was $66.6 million for the quarter ended June 30, 2023, as compared with $70.0 million for the quarter ended June 30, 2022.

NICOLAS CAGE'S RETIREMENT IS NOT QUITE WORKING OUT AS HE HAD IMAGINED. "THE RETIREMENT PLAN" HITS THEATERS AUGUST 25

Retrieved on: 
Wednesday, July 12, 2023
Aftermath, Ghostbusters, Reunion, Nicolas Cage filmography, The Unbearable Weight of Massive Talent, Cradle, Watchmen, Laughter, Island, Alien 3, The Crow, Pension, The Blackening, The Avatar Series, Hellboy, Quantum Leap, Risk, A Nightmare on Elm Street, Co-production (media), Treasure, Elm Street, Buckley's Chance, Face/Off, The Twilight Saga, Film industry

Their reunion is fleeting as they are soon tracked down by crime boss Donnie (Jackie Earle Haley) and his lieutenant (Ron Perlman).

Key Points: 
  • Their reunion is fleeting as they are soon tracked down by crime boss Donnie (Jackie Earle Haley) and his lieutenant (Ron Perlman).
  • "I am thrilled to be working with Falling Forward and Productivity Media on the theatrical release of this film," says director Tim Brown.
  • "This film is destined to be another classic Nic Cage action comedy," says Scott Kennedy, President of Falling Forward Films.
  • "The Retirement Plan" is set for release in North America on August 25.

Global Quantum Sensors Strategic Business Report 2023: Quantum Sensors to Make Oil & Gas Operations Safer & More Efficient

Retrieved on: 
Wednesday, June 28, 2023
Real, Quantum sensor, The Post-Pandemic World Order, Unemployment, Federally Administered Tribal Areas, Virus, Way, Rail transport by country, Build automation, Communication, COVID-19, South African Unemployed Peoples' Movement, Dawn, Death, Quantum Leap, Business opportunity, Consumer, Quantum computing, Deaths due to the Chernobyl disaster, Vaccine, IMF, Country, Microscope, Pharmaceutical industry, Video game, Quantum

From Quantum Computing to Quantum Sensing, Quantum Resources & Technologies Are Edging Closer to Commercialization

Key Points: 
  • From Quantum Computing to Quantum Sensing, Quantum Resources & Technologies Are Edging Closer to Commercialization
    The Quantum World Sees the Light of Commercialization: Global Market Opportunity for Quantum Computing (In US$ Million) for Years 2021, 2023, 2025 and 2027
    The Never-Ending "Race" Between the Virus & Vaccines Continues.
  • Amidst this Chaotic Battle, Where is the World Economy Heading Now & Beyond?
  • With New Strains Emerging at an Alarming Rate, Focus Shifts to Booster Doses & Vaccine Tweaking.
  • Here's How
    Robust Defense Spending Opens Opportunities for Quantum Sensing in Military & Defense Applications: World Military Expenditure (In US$ Billion) for Years 2019, 2020 and 2021
    A Peek Into the Growing Role of Quantum Sensors in Military Applications?

Atossa Therapeutics and Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen Arm of Ongoing I-SPY 2 Clinical Trial

Retrieved on: 
Wednesday, June 28, 2023
FNIH, University, Neoplasm, University of California, San Francisco, Clinical trial, Breast, Woman, EOP, Bangladesh Technical Education Board, Biomarker, SERM, Quantum Leap, Patient, Risk, SAN, FDA, Therapy, Recurrence, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Breast cancer, Pharmaceutical industry

The I-SPY 2 TRIAL is a collaborative effort among academic investigators from major cancer research centers across the United States, Quantum Leap Healthcare Collaborative, the U.S. Food and Drug Administration, and the Foundation for the National Institutes of Health (FNIH) Cancer Biomarkers Consortium.

Key Points: 
  • The I-SPY 2 TRIAL is a collaborative effort among academic investigators from major cancer research centers across the United States, Quantum Leap Healthcare Collaborative, the U.S. Food and Drug Administration, and the Foundation for the National Institutes of Health (FNIH) Cancer Biomarkers Consortium.
  • The (Z)-endoxifen treatment arm, which is expected to enroll approximately 20 patients, is part of the I-SPY 2 Endocrine Optimization Pilot Protocol (EOP).
  • Patients will receive 10 mg of (Z)-endoxifen daily for up to 24 weeks prior to surgery.
  • But one of the biggest challenges in breast cancer is the hormone positive breast cancers that are slow growing.